[1]
D. Havrylyuk, B. Zimenkovsky, I. Drapak, V. Atamanyuk, and R. Lesyk, “Docking and QSAR analysis of 4-(3,5-diphenyl-4,5-dihydro-pyrazol-l-yl)-l,3- thiazol-2(5H)-ones with anticancer activity in vitro”, Farm Zh, no. 6, pp. 69-75, Jul. 2020.